Skip to main content

Find Clinical Trials

Home
Conditions
Nephritis

Clinical trial condition

Nephritis

Explore clinical trials studying Nephritis. Study availability and eligibility vary by location and protocol.

638 public trials 186 recruiting studies

Refine in advanced search Browse all conditions

Nephritis trial results

Completed

Mycophenolate Mofetil in Membranous Nephropathy

NCT00135967

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations: Department of Nephrology Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Completed

Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis

NCT00154661

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +6 more
Locations: Yung-Ming Chen Taipei, Taiwan

View Trial Details

Completed

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

NCT00006137

Conditions: Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

NCT00004305

Conditions: Autoimmune Diseases, Disease Attributes, Female Urogenital Diseases, +13 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

NCT00106561

Conditions: Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, +16 more
Locations: Department of Nephrology, The Royal Melbourne Hospital Melbourne, Victoria, Australia

View Trial Details

Terminated

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT06342960

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations: Charite- Universitätsklinikum Berlin Berlin, Germany

Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany

Universitätsklinikum Düsseldorf Düsseldorf, Germany

Universitätsklinikum Erlangen Erlangen, Germany

View Trial Details

Terminated

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT05938725

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations: Stanford University Medical Center Palo Alto, California, United States

University of Colorado Denver, Colorado, United States

University of Massachusetts Worcester Worcester, Massachusetts, United States

Northwell Health Great Neck, New York, United States

View Trial Details

Withdrawn

A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)

NCT06984341

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations: University of Alabama at Birmingham: The Kirklin Clinic Birmingham, Alabama, United States

University of Iowa Iowa City, Iowa, United States

View Trial Details